In a study published online February 2nd 2018 in Nature Communications, scientists from the Icahn School of Medicine at Mount Sinai describe an extensive analysis of novel grape-derived compounds, dihydrocaffeic acid (DHCA) and malvidin-3′-O-glucoside (Mal-gluc),which might be developed as therapeutic agents for the treatment of depression. The study results indicate that these natural compounds may… Continue reading Researchers Find That Grape-Derived Compounds May Promote Resilience Against Depression